Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

As College Drinking Problems Rise, New Studies Identify Effective Prevention Strategies
Alcohol-related deaths among U.S. college students rose from 1,440 deaths in 1998 to 1,825 in 2005, along with increases in heavy drinking and drunk driving, according to an article in the July supplement of the Journal of Studies on Alcohol and Drugs.

ARIAD Announces Preliminary Results From Ongoing Clinical Trial Of Its Investigational, Bcr-Abl Inhibitor In Drug-Resistant Chronic Myeloid Leukemia
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced preliminary clinical data from an ongoing Phase 1 clinical trial of its investigational, multi-targeted kinase inhibitor, AP24534, in patients with advanced hematological cancers. The study results provide initial clinical evidence of hematologic, cytogenetic and molecular anti-cancer activity of AP24534 in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML), including those with the T315I mutant variant of the target protein, Bcr-Abl. An abstract describing these data is being submitted for presentation at a major hematology meeting to be held later this year.
News of the day
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Boston Scientific Corporation (NYSE: BSX) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and joins the TAXUS(R) Express(R) Atom(TM) Stent as the only drug-eluting stents approved for small vessel use in the U.S. The Company plans to begin a full U.S. launch of TAXUS Liberte Atom next month.
Endocrinology

UPMC Again Named To U.S. News & World Report Honor Roll Of America's Best Hospitals For The 10th Time

UPMC is once again the region"s only medical center named on the annual U.S. News & World Report Honor Roll of America"s Best Hospitals. UPMC is ranked 13th of only 21 hospitals nationwide who made the Honor Roll of the "nation"s best" in the 2009 survey. UPMC was ranked in 13 of 16 specialty areas, including seven specialties for which UPMC is in the top 10. Once again, UPMC is the region"s only medical center to be ranked in any specialty. Only 174 hospitals of the more than 4,800 eligible hospitals nationally were ranked in any specialty area. This year marks UPMC"s 10th appearance on the Honor Roll, with UPMC advancing to 13th place, up from 14th place on the 2008 list. "This well-deserved recognition is due to our superb physicians, nurses and staff and is a clear reflection of their commitment to providing exceptional patient care," said Elizabeth Concordia, executive vice president of UPMC and president of the Hospital and Community Services Division. According to U.S. News & World Report, the Honor Roll lists those institutions that demonstrate excellence and breadth of expertise by ranking at or near the top in at least six specialties. UPMC"s ranked specialties are: Ear, nose and throat - ranked 4th; gynecology, 7th; respiratory disorders, 7th; geriatric care, 8th; psychiatry, 8th; orthopaedics, 10th; rheumatology, 10th; kidney disorders, 12th; rehabilitation, 14th; neurology and neurosurgery, 17th; digestive disorders, 18th; heart and heart surgery, 32nd; and cancer, 41st. The 2009-10 publication of America"s Best Hospitals is accessible online now at http://www.usnews.com/besthospitals and on sale at newsstands beginning Tuesday, July 21. University of Pittsburgh


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009